VolitionRx advances cancer detection tech and veterinary diagnostics Feb 25, 2026 08:11AM
VolitionRx names Medical & Biological Laboratories as Japan distributor Feb 10, 2026 08:07AM
VolitionRx receives NYSE American non-compliance notice Feb 9, 2026 05:27PM
Volition adds two lab providers for canine cancer test Jan 20, 2026 08:26AM
VolitionRx secures $2 million funding from Lind Global Asset Management Jan 8, 2026 09:15AM


Jan 8, 2026 08:46AM VolitionRx reports feline cancer test detects 80% of lymphomas
Dec 17, 2025 08:45AM VolitionRx receives first clinical order for cancer test
Nov 25, 2025 08:45AM VolitionRx sells first Nu.Q cancer assays to French hospital
Nov 21, 2025 12:29PM VolitionRX (VNRX) PT Lowered to $1 at Freedom Capital Markets
Nov 18, 2025 06:52AM VolitionRX (VNRX) PT Lowered to $1.50 at H.C. Wainwright
Sep 30, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on VolitionRX (VNRX)
Sep 29, 2025 09:31AM VolitionRx signs co-marketing deal with Hologic for discovery service
Sep 15, 2025 08:55AM Benchmark Reiterates Hold Rating on VolitionRX (VNRX)
Sep 10, 2025 07:32AM H.C. Wainwright Reiterates Buy Rating on VolitionRX (VNRX)
Sep 9, 2025 08:47AM VolitionRx signs licensing deal with Werfen for blood clot test
Jun 12, 2025 08:32AM Volitionrx Limited (VNRX) Announces MARS Consortium Clinical Study Suggests Nu.Q H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure
Jun 9, 2025 04:31PM Jones Trading Starts VolitionRX (VNRX) at Buy
May 19, 2025 09:19AM Benchmark Reiterates Hold Rating on VolitionRX (VNRX)
May 16, 2025 07:09AM Volitionrx Limited (VNRX) Misses Q1 EPS by 2c
Apr 11, 2025 06:39AM H.C. Wainwright Reiterates Buy Rating on VolitionRX (VNRX)
Apr 8, 2025 09:36AM Benchmark Reiterates Hold Rating on VolitionRX (VNRX)
Mar 26, 2025 08:00AM Volitionrx Limited (VNRX) Prices $2.3M Share Offering
Mar 21, 2025 08:32AM Volitionrx (VNRX) says study shows Nu.Q Cancer immunoassay test in development detected a range of 21 different cancers
Mar 13, 2025 08:30AM Volitionrx Limited (VNRX) Signs first ever Nu.Q Vet Cancer Test Automation Agreement with Fujifilm Vet Systems
Jan 8, 2025 08:32AM Volitionrx Limited (VNRX) Issues Business Review 2024
Jan 8, 2025 08:32AM Volitionrx Limited (VNRX) Issues Business Review 2024
Dec 6, 2024 09:00AM Volitionrx Limited (VNRX) Announces Pricing of up to $1.9 Million Registered Direct Offering
Sep 30, 2024 04:10PM Volitionrx Limited (VNRX) Appoints Ethel Rubin to its Board
Aug 9, 2024 08:01AM Volitionrx Limited (VNRX) Prices $21.5M Share and Warrant Offering